awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53675120-9E5D8921-4FB0-4B73-B4C2-3250C399B284
Q53675120-9E5D8921-4FB0-4B73-B4C2-3250C399B284
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53675120-9E5D8921-4FB0-4B73-B4C2-3250C399B284
Assessing the benefit of bone-targeted therapies in prostate cancer, is the devil in the end point's definition?
P2860
Q53675120-9E5D8921-4FB0-4B73-B4C2-3250C399B284
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53675120-9E5D8921-4FB0-4B73-B4C2-3250C399B284
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e24dd937ef4e976f7f83f58201217f4c0dcaa156
P2860
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.